Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 150 Mcg (0.15 Mg), 1000-count Bottles
Recall Summary Accord Healthcare is recalling 1,000-count bottles of Levothyroxine Sodium Tablets (150 mcg) because the medication is subpotent, meaning it contains less active ingredient than labeled. The affected product was distributed nationwide across all U.S. states and the District of Columbia. This is a prescription thyroid medication manufactured in India for Accord Healthcare.
- Recalling firm
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17.
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/4d522546-9553-4ea2-bead-72fa1faa9e26